These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 30911883

  • 1. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography for evaluating lymph node metastasis in patients with lung cancer: a prospective study.
    Shinya T, Otomi Y, Kubo M, Kinoshita M, Takechi K, Uyama N, Yamanaka M, Terazawa K, Toba H, Bando Y, Otsuka H, Harada M.
    Ann Nucl Med; 2019 Jun; 33(6):414-423. PubMed ID: 30911883
    [Abstract] [Full Text] [Related]

  • 2. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
    Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.
    Clin Nucl Med; 2009 Apr; 34(4):216-21. PubMed ID: 19300050
    [Abstract] [Full Text] [Related]

  • 3. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Yamanaka M, Shinya T, Otomi Y, Kubo M, Arai Y, Toba H, Bando Y, Otsuka H, Harada M.
    Nucl Med Commun; 2020 Nov; 41(11):1189-1198. PubMed ID: 32796454
    [Abstract] [Full Text] [Related]

  • 4. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [Abstract] [Full Text] [Related]

  • 5. The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
    Wumener X, Zhang Y, Zang Z, Ye X, Zhao J, Zhao J, Liang Y.
    Ann Nucl Med; 2024 Nov; 38(11):904-912. PubMed ID: 39078558
    [Abstract] [Full Text] [Related]

  • 6. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes.
    Park S, Paeng JC, Kang CH, Cheon GJ, Kang KW, Chung JK, Lee DS.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1317-1328. PubMed ID: 29502309
    [Abstract] [Full Text] [Related]

  • 7. The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.
    Lee JW, Kim EY, Kim DJ, Lee JH, Kang WJ, Lee JD, Yun M.
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of Dual-Timepoint 18F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar Cancer.
    Collarino A, Garganese G, Valdés Olmos RA, Stefanelli A, Perotti G, Mirk P, Fragomeni SM, Ieria FP, Scambia G, Giordano A, Rufini V.
    J Nucl Med; 2017 Dec; 58(12):1913-1918. PubMed ID: 28546331
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K, Nakamura S, Sugiyama T, Kadomatsu Y, Ueno H, Goto M, Ozeki N, Fukui T, Iwano S, Chen-Yoshikawa TF.
    BMC Cancer; 2021 Sep 02; 21(1):983. PubMed ID: 34474680
    [Abstract] [Full Text] [Related]

  • 10. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW.
    Cancer Imaging; 2018 Sep 14; 18(1):32. PubMed ID: 30217167
    [Abstract] [Full Text] [Related]

  • 12. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Results from a High-volume Centre Including Long-term Follow-up.
    Vind-Kezunovic S, Bouchelouche K, Ipsen P, Høyer S, Bell C, Bjerggaard Jensen J.
    Eur Urol Focus; 2019 Jan 14; 5(1):90-96. PubMed ID: 28753817
    [Abstract] [Full Text] [Related]

  • 13. Preliminary clinical assessment of dynamic 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for evaluating the clinicopathological grade in patients with non-Hodgkin's lymphoma: a prospective study.
    Shinya T, Otomi Y, Dimitrakopoulou-Strauss A, Kubo M, Kondo M, Otomo M, Terazawa K, Bando Y, Harada M.
    Nucl Med Commun; 2020 Jan 14; 41(1):26-33. PubMed ID: 31800508
    [Abstract] [Full Text] [Related]

  • 14. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y, Suga K, Matsunaga N.
    Ann Nucl Med; 2016 May 14; 30(4):287-97. PubMed ID: 27007128
    [Abstract] [Full Text] [Related]

  • 15. Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.
    Rogasch JM, Steffen IG, Riedel S, Apostolova I, Wertzel H, Achenbach HJ, Steinkrüger FL, Kalinski T, Schultz M, Schreiber J, Amthauer H, Furth C.
    Eur Radiol; 2016 Aug 14; 26(8):2808-18. PubMed ID: 26560731
    [Abstract] [Full Text] [Related]

  • 16. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
    Sürücü E, Polack BD, Demir Y, Durmuşoğlu M, Ekmekçi S, Sarıoğlu S, Çelik AO, Ada E, İkiz AÖ.
    Clin Imaging; 2015 Aug 14; 39(5):781-6. PubMed ID: 25721710
    [Abstract] [Full Text] [Related]

  • 17. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A.
    Clin Lung Cancer; 2015 Nov 14; 16(6):e253-8. PubMed ID: 26163919
    [Abstract] [Full Text] [Related]

  • 18. [18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study.
    Li Y, Zhang Y, Guo Z, Hou P, Lv J, Ke M, Liu S, Li S, Yin W, He J, Wang X.
    Cancer Imaging; 2024 Jun 03; 24(1):68. PubMed ID: 38831354
    [Abstract] [Full Text] [Related]

  • 19. Improving diagnostic performance of 18F-FDG-PET/CT for assessment of regional nodal involvement in non-small cell lung cancer.
    Yang DD, Mirvis E, Goldring J, Patel ARC, Wagner T.
    Clin Radiol; 2019 Oct 03; 74(10):818.e17-818.e23. PubMed ID: 31420186
    [Abstract] [Full Text] [Related]

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Oct 03; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.